ESC 2026: ESC 2026: Head-to-head study compares inclisiran and bempedoic acid
This year at the European Society of Cardiology (ESC) Scientific Sessions, results from the Phase IV VICTORION-CHALLENGE trial provided the…
Analyst Comment
ESC 2026: enlicitide extends oral PCSK9 benefits beyond LDL-C lowering
ESC 2026: laroprovstat evaluated to close the LDL-C treatment gap
Surveillance and vaccine could protect against higher cancer risk from Lynch syndrome
US Executive Order 14420 and potential implications for diphtheria vaccination
AstraZeneca trips in PD-1 bispecific market after Phase III NSCLC failure
Study finds metabolic biomarker signature to assist with early HNSCC detection
The changing landscape of childhood infectious disease in the US
